Cessatech Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cessatech
Access all reports
Cessatech A/S is a biopharmaceutical company dedicated to identifying, developing and commercializing drugs for children with the potential to treat cancer and fibrotic disorders. The company's focus of research and development is based on the proteins in regulatory T-cells (Tregs) that suppress an immune system response to secondary disease processes, such as cancer and fibrosis.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇩🇰 Denmark